Search

CRISPR and bioengineering are hot topics from our Cell + Gene Curator roundup.

After years of speculation, we reveal what Brexit really means for pharma – so far.

To demonstrate fast, highly sensitive quantitation of nine nitrosamines with a Thermo Scientific Orbitrap Exploris 120 mass spectrometer

And the winner of The Medicine Maker 2020 Innovation Awards is…

When it comes to clinical trials, is pharma making the best use of digital technologies?

What is the single greatest challenge facing the cell and gene therapy industry in 2021?

Sputnik V (finally and definitely) starts rolling review with the EMA.

Does pharma really need to pay a high price when it comes to synthetic chemistry?

High-level purification maximizes the amount of therapeutic gene payload being delivered with each vector to reduce the risk of immune reaction.

If you could expand into a new therapeutic space, should you? And what’s the right path forward, if you make the leap?